We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current XRTX market cap is 5.48M. The company's latest EPS is CAD -1.0796 and P/E is -3.60.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.49M | -3.42M | -1.69M | -1.4M | -1.16M |
| Net Income | -1.56M | -2.92M | -1.83M | -1.69M | -1.33M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -368k | -1.14M | -2.42M | -12.33M | -5.53M |
| Net Income | -629k | -1.28M | -1.65M | -9.49M | -2.16M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 14.96M | 16.75M | 9.66M | 7.8M | 6.64M |
| Total Liabilities | 4.25M | 7.29M | 599k | 403k | 554k |
| Total Equity | 10.71M | 9.47M | 9.06M | 7.4M | 6.09M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 1.09M | 2.29M | 22.04M | 16.75M | 5.47M |
| Total Liabilities | 1.3M | 1.03M | 5.3M | 7.29M | 826k |
| Total Equity | -211k | 1.26M | 16.74M | 9.47M | 4.64M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -6.81M | -11.97M | -2.48M | -4.21M | -5.29M |
| Investing | -39k | -60k | -20k | -29k | -36k |
| Financing | -644k | 6.43M | -23k | -32k | -49k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -249k | -728k | -6.06M | -11.97M | -6.58M |
| Investing | -7k | -14k | -40k | -60k | -46k |
| Financing | 55k | 855k | 24.46M | 6.43M | -361k |
| Market Cap | 5.48M |
| Price to Earnings Ratio | -3.60 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.26 |
| Price to Book Ratio | 1.68 |
| Dividend Yield | - |
| Shares Outstanding | 2M |
| Average Volume (1 week) | 17.28k |
| Average Volume (1 Month) | 16.15k |
| 52 Week Change | -56.85% |
| 52 Week High | 7.524 |
| 52 Week Low | 1.98 |
| Spread (Intraday) | 0.2 (7.09%) |
| Company Name | XORTX Therapeutics Inc |
| Address |
550 burrard street, suite 2900 vancouver, british columbia V6C OA3 |
| Website | https://www.xortx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
